Job Opening: Bioprocess Development Scientist at Cytiva

Cytiva Sweden AB

Uppsala län, Uppsala

Previous experience is desired

5 days left
to apply for the job

Bring more to life.

Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology? At Cytiva, one of Danaher’s 15+ operating companies, our work saves lives—and we’re all united by a shared commitment to innovate for tangible impact.

You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life.

Working at Cytiva means being at the forefront of providing new solutions to transform human health. Our incredible customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, new medicines, and cell and gene therapies.

At Cytiva you will be able to continuously improve yourself and us – working on challenges that truly matter with people that care for each other, our customers, and their patients. Take your next step to an altogether life-changing career. Learn about the Danaher Business System which makes everything possible.

The Bioprocess Development Scientist is responsible for evaluating and optimizing Cytiva filtration technology in biopharmaceutical processes. The BDS advises customers on process options, runs filterability studies, and helps overcome filtration challenges in drug process development. This position is located remotely in Uppsala, Sweden and covers projects in the Nordics and Baltics territory. This position reports to the EMEA Filtration BPS Leader and is part of the BioPharma Process team and will be fully remote.

What you will do:

  • Engage in technical consultations with customers on downstream filtration processing where you evaluate and propose options for process optimization
  • Coordinate, perform and analyze bench scale test work at customer site for Cytiva filtration technologies in customer’s biopharmaceutical processes.
  • Serve as a technical specialist with in-depth knowledge of Cytiva products and downstream processing and develop expertise by regular exchange of experiences and trainings.
  • Join a dynamic cross-functional and cross-regional team of bioprocess scientists
  • Work in close relationship with sales specialists, account managers, and scientists to coordinate activities and win sales
  • Be part of the bringing future biopharmaceuticals to patients by supporting process development of molecules such as monoclonal antibodies, recombinant proteins or vaccines

Who you are:

  • Master’s Degree in Life Science, Chemical or Biological, or Engineering or related field required, PhD preferred
  • 5 plus years of relevant experience in biotech industry, preferably in downstream process development
  • Valid driver’s license
  • Willing to travel regionally (approximately 50%) with occasional travel outside assigned territory
  • English fluency required, Swedish language a plus
🖐 Was this job fit for someone?
Share

Other jobs in the same field

Maybe it’s time to broaden the search with these available jobs

Keyword / Occupation
Similar jobs
Latest posts
  • Electricity prices - Today's and Tomorrow's Electricity Prices in Sweden
    Wed, 8 Jan 2025 - 13:01
  • Promocode - Exclusive Fitness Offer: Train in 2025 for Half the Price with myMOWO!
    Fri, 3 Jan 2025 - 09:01
  • General - Statsskuld.se: New Tax Calculations & Job Search
    Thu, 2 Jan 2025 - 19:54
  • Public Opinion - Novus December 2024: Social Democrats on Top
    Tue, 31 Dec 2024 - 14:35
  • Loan - Mortgage Interest Rates in Sweden 2024-2026: Forecast and Advice
    Sat, 28 Dec 2024 - 11:48
  • Swedens Policy Rate - The Central Bank lowers the policy rate: How does it affect your economy?
    Fri, 20 Dec 2024 - 11:48
  • Information about Statsskuld.se - Improvements on Statsskuld.se: News & Updates
    Tue, 17 Dec 2024 - 08:56
  • Inflation - Inflation in Sweden November 2024: KPIF at 1.8%
    Thu, 12 Dec 2024 - 08:36